ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 65

Barriers at School for Children with Juvenile Idiopathic Arthritis (JIA) –A Patient Reported Outcome

Kelsey Chomistek1, Nicole Johnson2, Rebeka Stevenson2, Nadia Luca3, Paivi Miettunen2, Susanne Benseler3, Dwaraka Veeramreddy4 and Heinrike Schmeling5, 1Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada, 2Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 3Pediatric Rheumatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada, 4Department of Pediatrics/Alberta Children's Hospital, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada, 5University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Juvenile idiopathic arthritis (JIA) and patient-reported outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose:

Few studies in children with chronic illnesses/disability have reported challenges faced by patients at school. Therefore, the objective of this study is to identify barriers and their associated impact in Juvenile Idiopathic Arthritis (JIA).

Methods:

A cross-sectional observational study of children aged 8 to 17 diagnosed with JIA followed at the Rheumatology Clinic/Alberta Children’s Hospital was performed between July and December 2016. Demographics, diagnosis and disease course were obtained from health records. A survey was administered to the child/caregiver to assess the barriers experienced by JIA patients at school. The questionnaire collected information about school attendance/performance, impact of JIA symptoms (e.g. pain, fatigue), challenges and accommodations, communication, participation/peers, and school support. Descriptive statistics were used to analyze the data. 

 

Results:

A total of 66 children were recruited into the study. The median age of participants was 13 (range 8-17). The most common subtypes were rheumatoid factor negative polyarticular JIA (34.8%) and oligoarticular persistent JIA (31.8%) with a median disease duration of 5.3 years (range 0-12). The treatment included DMARDS (68.2%), NSAIDS (43.9%), biologics (42.4%), steroids (4.55%) and no medication (9.1%).

Appointments, illness and JIA symptoms had a minor impact on school attendance and performance. However, physical challenges (e.g. gym, writing, sitting for long periods of time) at school were a barrier for 41.6% (sometimes 27.7%, often 10.8%, almost always 3.1%). 20.6% recorded using accommodations (e.g. accommodation letter, modified gym, computer access). Patients were unable to participate in activities in class/outside with their peers (37.5%; sometimes 32.8%, almost always 4.7%) and in gym (38%; sometimes 32.8%, often 5.2%). Patients told their teachers/gym teacher about their disease (82.0%) but most patients did not continue to update their teachers. 11.1% of participants reported that their teachers did not understand their illness compared to 19.2% of gym teachers. 84.3% of participants told their friends about their illness and 41.9% told their classmates. Social concerns included anxiety about being unable to participate in school related activities, being treated differently, and looking like they weren’t trying. The majority reported that the school was supportive of their illness (92.3%). Barriers tend to be reported more often by patients with active disease.

Conclusion:

JIA had a minor impact on school attendance and performance. However, many patients experienced some impacting physical challenges. Additional barriers included teacher understanding, participation and social anxiety.

 


Disclosure: K. Chomistek, None; N. Johnson, None; R. Stevenson, None; N. Luca, None; P. Miettunen, None; S. Benseler, None; D. Veeramreddy, None; H. Schmeling, None.

To cite this abstract in AMA style:

Chomistek K, Johnson N, Stevenson R, Luca N, Miettunen P, Benseler S, Veeramreddy D, Schmeling H. Barriers at School for Children with Juvenile Idiopathic Arthritis (JIA) –A Patient Reported Outcome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/barriers-at-school-for-children-with-juvenile-idiopathic-arthritis-jia-a-patient-reported-outcome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/barriers-at-school-for-children-with-juvenile-idiopathic-arthritis-jia-a-patient-reported-outcome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology